Applied Genetic Technologies Corp. (NASDAQ: AGTC) Featured in Virtual Coverage of the 33rd Annual ROTH Conference
Applied Genetic Technologies Corp. (NASDAQ: AGTC) is a clinical-stage biotechnology company developing genetic therapies for people with rare and debilitating ophthalmic, otologic and central nervous system (CNS) diseases. AGTC is a leader in designing and constructing all critical gene therapy elements and bringing them together to develop customized therapies that address real patient needs. AGTC’s most advanced clinical programs leverage its best-in-class technology platform to…